Stocks to sell

Life sciences equipment manufacturer Bionano Genomics (NASDAQ:BNGO) was a popular meme stock last year. Consequently, its management raised a massive amount of cash through equity offerings. However, it has failed to sustain investor interest, as its flagship optimal genome mapping tool Saphyr hasn’t gained much traction in the medical community. It continues to grow at
0 Comments
QuantumScape (NYSE:QS) is a speculative pre-revenue stage company operating in the next-generation electric battery industry. The company claims to have advanced technology that could represent a great leap forward in electric battery performance. However, short sellers published scathing criticisms of QuantumScape’s technology and management team last year, leading to a massive decline. QS stock is
0 Comments
AT&T’s (NYSE:T) latest quarterly results did not inspire confidence. Shares of the world’s biggest telecommunications company fell 10% following the latest financial results that showed a further decline in the company’s wireless business. T stock opened at $24.06 on Jan. 27. Source: Jonathan Weiss/Shutterstock That AT&T’s streaming platform, HBO Max, performed better than expected in
0 Comments
Opendoor Technologies (NASDAQ:OPEN) stock is not in a good place, which is a little hard to understand. Source: PREMIO STOCK/Shutterstock.com The company is tied to a win-win platform with the iBuyer business model, the mechanism that enables it to buy homes quickly for subsequent flipping. It was essentially real estate agent-free. The iBuyer model undergirding OPEN
0 Comments
At just under $2.50 per share, there’s no question that ContextLogic (NASDAQ:WISH) is a low-priced stock. But is WISH stock a cheap stock, in terms of valuation? That’s another question entirely. Source: sdx15 / Shutterstock.com Sure, with a market capitalization of $1.4 billion, against $2.59 billion of trailing 12-month sales, its price-sales (P/S) ratio of around
0 Comments